Amedica announces private label supply agreement with BoTEC Medical

Amedica Corporation recently announced a private label supply agreement with BoTEC Medical.

“This strategic alliance further validates the market adoption of our medical-grade silicon nitride technology platform internationally,” B. Sonny Bal, MD, JD, MBA, chairman and chief executive officer of Amedica, said in a press release. “Since launching our second generation silicon nitride interbody fusion devices in 2014, we have been pursuing a multi-channel approach to provide broader accessibility to our proprietary silicon nitride biomaterial. We are very pleased to partner with BoTEC Medical’s team and look forward to participating in their exciting future as they continue to capture additional market share within and outside one of the fastest growing medical device markets in the world.”

Under the terms of the nonexclusive private label agreement, Amedica will provide proprietary silicon nitride spinal interbody devices to BoTEC Medical to be distributed and sold in their worldwide markets.

“We are very pleased to enter into this partnership with Amedica, as they have a unique biomaterial platform that will provide BoTEC Medical interbody solutions with a unique value proposition in a highly competitive market,” Waldo Shan, chief executive officer of BoTEC Medical, said in the press release. “We look forward to building upon our partnership to meet the ever-increasing surgeon demands while improving patient lives.”

Reference: